Liposomal Drug Delivery against <i>Helicobacter pylori</i> Using Furazolidone and N-Acetyl Cysteine in Augmented Therapy
<i>Helicobacter pylori</i> (<i>H. pylori</i>) infection is a significant global health concern, affecting approximately 50% of the world's population and leading to gastric ulcers, gastritis, and gastric cancer. The increase in antibiotic resistance has compromised the e...
Saved in:
Main Authors: | Muhammad Irfan Alam (Author), Timothy Paget (Author), Najla Yussuf Moosa (Author), Husein Alghurairy (Author), Amal Ali Elkordy (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Point Mutations in Furazolidone and Rifampicin Resistance Genes in <i>Helicobacter pylori</i> Strains from Colombia
by: Kevin Andres Guzman, et al.
Published: (2024) -
<i>N</i>-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases
by: Marcos Martinez-Banaclocha
Published: (2022) -
Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
by: Min Niu, et al.
Published: (2022) -
Rescue Therapy with Furazolidone in Patients with at Least Five Eradication Treatment Failures and Multi-Resistant <i>H. pylori</i> infection
by: Elena Resina, et al.
Published: (2021) -
Furazolidona, tetraciclina e omeprazol: uma alternativa de baixo custo para erradicação de Helicobacter pylori em crianças Furazolidone, tetracycline and omeprazole: a low-cost alternative for Helicobacter pylori eradication in children
by: Rodrigo Strehl Machado, et al.
Published: (2008)